Acquisition Opportunity Vital Data Technology was recently acquired by MedReview, creating a combined footprint in payer workflow and data technology. This presents a cross-sell or upsell path to MedReview’s existing payer customers and an opportunity to align integrations between Affinitē and MedReview’s payment integrity solutions.

Strategic Partnerships Past and ongoing collaborations with health networks such as Mid State Health Network and Colorado Access indicate a proven track record of partnership-driven growth. Sales teams can target additional regional payers and networks seeking predictive analytics, risk adjustment, and care management capabilities.

AI driven Value Affinitē combines AI, predictive data science, and intelligent automation within a cloud-native platform to address population health, value-based care, and prior authorization. This positions the company to pursue health plans aiming to optimize cost of care and member outcomes, especially in risk-adjusted populations.

Regulatory & Quality Momentum NCQA certifications and prevalidations for HEDIS and Population Health Management signal credibility in quality measurement and regulatory readiness. Potential upsell to clients seeking compliant, measurable quality improvement and performance reporting in payer programs.

Growth and Scale With a mid-market focus (employees 11-50) and revenue in the lower tens of millions, there is scalability room through expanded deployments, additional modules within Affinitē, and regional expansions to health plans looking for integrated analytics, utilization, and care management workflows.